Bruce Middleton

884 total citations
47 papers, 700 citations indexed

About

Bruce Middleton is a scholar working on Molecular Biology, Surgery and Clinical Biochemistry. According to data from OpenAlex, Bruce Middleton has authored 47 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 17 papers in Surgery and 14 papers in Clinical Biochemistry. Recurrent topics in Bruce Middleton's work include Metabolism and Genetic Disorders (13 papers), Cholesterol and Lipid Metabolism (13 papers) and Lipoproteins and Cardiovascular Health (7 papers). Bruce Middleton is often cited by papers focused on Metabolism and Genetic Disorders (13 papers), Cholesterol and Lipid Metabolism (13 papers) and Lipoproteins and Cardiovascular Health (7 papers). Bruce Middleton collaborates with scholars based in United Kingdom, United States and Saudi Arabia. Bruce Middleton's co-authors include K. Bartlett, R. J. Pollitt, David A. White, G. D. Bell, Richard J. Clegg, Anders Paetau, Tiina Tyni, Tero Kivelä, Arnold W. Strauss and Claude Sansaricq and has published in prestigious journals such as PEDIATRICS, Biochemical and Biophysical Research Communications and Archives of Biochemistry and Biophysics.

In The Last Decade

Bruce Middleton

46 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce Middleton United Kingdom 15 435 295 125 99 60 47 700
M S Murthy Canada 15 609 1.4× 442 1.5× 125 1.0× 23 0.2× 45 0.8× 29 860
Michael D. Greenspan United States 15 470 1.1× 66 0.2× 67 0.5× 121 1.2× 89 1.5× 23 686
Masakazu Ogata Japan 15 196 0.5× 123 0.4× 112 0.9× 53 0.5× 30 0.5× 18 730
A J Clifford United States 15 424 1.0× 84 0.3× 78 0.6× 36 0.4× 80 1.3× 29 917
Kévin Ragot France 15 425 1.0× 59 0.2× 119 1.0× 237 2.4× 46 0.8× 18 744
Anne J. Smith United States 11 638 1.5× 72 0.2× 298 2.4× 79 0.8× 219 3.6× 11 889
Lawrence M. Zaccaro United States 9 269 0.6× 35 0.1× 71 0.6× 116 1.2× 40 0.7× 12 535
Hee Yeon Kim South Korea 18 351 0.8× 75 0.3× 207 1.7× 30 0.3× 28 0.5× 60 892
Kenneth H. Shull United States 16 452 1.0× 176 0.6× 222 1.8× 81 0.8× 165 2.8× 26 1.0k
Theodore W. C. Lo United Kingdom 10 617 1.4× 756 2.6× 333 2.7× 26 0.3× 90 1.5× 14 1.3k

Countries citing papers authored by Bruce Middleton

Since Specialization
Citations

This map shows the geographic impact of Bruce Middleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Middleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Middleton more than expected).

Fields of papers citing papers by Bruce Middleton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Middleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Middleton. The network helps show where Bruce Middleton may publish in the future.

Co-authorship network of co-authors of Bruce Middleton

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Middleton. A scholar is included among the top collaborators of Bruce Middleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Middleton. Bruce Middleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zamzami, Mazin A., et al.. (2016). POSSIBLE REGULATION OF LDL-RECEPTOR BY NARINGENIN IN HEPG2 HEPATOMA CELL LINE. African Journal of Traditional Complementary and Alternative Medicines. 14(1). 278–287. 15 indexed citations
2.
Choudhry, Hani, et al.. (2016). Role of hesperetin in LDL-receptor expression in hepatoma HepG2 cells. BMC Complementary and Alternative Medicine. 16(1). 182–182. 22 indexed citations
3.
Eaton, Simon, Bruce Middleton, H. S. A. Sherratt, et al.. (2006). Control of Mitochondrial β-Oxidation at the Levels of [NAD+]/[NADH] and CoA Acylation. Kluwer Academic Publishers eBooks. 466. 145–154. 6 indexed citations
4.
Middleton, Bruce. (2005). Cyber Crime Investigator's Field Guide. Auerbach Publications eBooks. 1 indexed citations
5.
Tyni, Tiina, Anders Paetau, Arnold W. Strauss, Bruce Middleton, & Tero Kivelä. (2004). Mitochondrial Fatty Acid β-Oxidation in the Human Eye and Brain: Implications for the Retinopathy of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency. Pediatric Research. 56(5). 744–750. 59 indexed citations
6.
7.
Glasgow, J. F. T., et al.. (1999). The mechanism of inhibition of β-oxidation by aspirin metabolites in skin fibroblasts from Reye’s syndrome patients and controls. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1454(1). 115–125. 43 indexed citations
8.
Snyderman, Selma E., Claude Sansaricq, & Bruce Middleton. (1998). Succinyl-CoA:3-Ketoacid CoA-Transferase Deficiency. PEDIATRICS. 101(4). 709–711. 27 indexed citations
9.
Eaton, Simon, Bruce Middleton, & K. Bartlett. (1998). Control of mitochondrial β-oxidation: sensitivity of the trifunctional protein to [NAD+]/[NADH] and [acetyl-CoA]/[CoA]. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1429(1). 230–238. 23 indexed citations
10.
Middleton, Bruce, et al.. (1998). Elevation of cyclic AMP by iloprost and prostaglandin E1 increases cholesterol efflux and the binding capacity for high-density lipoproteins in human fibroblasts. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1391(2). 117–132. 4 indexed citations
11.
Middleton, Bruce, et al.. (1996). Elevation of cyclic AMP in human skin fibroblasts results in increased capacity for HDL binding. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1302(1). 84–92. 2 indexed citations
12.
Middleton, Bruce, et al.. (1993). The inhibition of cholesterol esterification by cyclandelate in transformed mouse macrophages. Biochemical Pharmacology. 45(9). 1829–1834. 2 indexed citations
13.
Middleton, Bruce, et al.. (1993). Cyclic AMP plays a role in regulating HDL binding to human cells in culture. Biochemical Society Transactions. 21(3). 230S–230S. 1 indexed citations
14.
Hartley, Richard C., et al.. (1993). Cyclic AMP-mediated hormonal control of LDL receptor activity in cultured human cells. Biochemical Society Transactions. 21(2). 130S–130S. 1 indexed citations
15.
Pollitt, R. J., et al.. (1992). Human liver long-chain 3-hydroxyacyl-coenzyme a dehydrogenase is a multifunctional membrane-bound beta-oxidation enzyme of mitochondria. Biochemical and Biophysical Research Communications. 183(2). 443–448. 124 indexed citations
16.
Middleton, Bruce. (1992). Lysosome inhibitors enhance the ability of cyclic AMP-elevating agents to induce the LDL receptor in human vascular smooth muscle cells. Biochemical and Biophysical Research Communications. 182(2). 830–835. 4 indexed citations
17.
Middleton, Bruce, Brian H. Robinson, W. G. Sherwood, et al.. (1990). 3-Oxothiolase Activities and [14C]-2-Methylbutanoic Acid Incorporation in Cultured Fibroblasts from 13 Cases of Suspected 3-Oxothiolase Deficiency. Pediatric Research. 28(5). 518–522. 17 indexed citations
18.
Middleton, Bruce, et al.. (1990). Inhibition of acyl coenzyme a: Cholesterol acyl transferase by trimethylcyclohexanylmandelate (cyclandelate). Biochemical Pharmacology. 39(3). 575–580. 9 indexed citations
19.
Salter, Andrew M., Madeha N. Al‐Seeni, David N. Brindley, & Bruce Middleton. (1989). Inhibition of cholesterol esterification in rat hepatocytes is necessary for down-regulation of low-density-lipoprotein receptor activity. Biochemical Society Transactions. 17(1). 112–113. 1 indexed citations
20.
White, David, et al.. (1989). The consequences of acyl coenzyme A: cholesterol acyltransferase inhibition by cyclandelate on low-density lipoprotein metabolism by J774 macrophages. Biochemical Society Transactions. 17(1). 127–128. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M S Murthy Breakdown of academic impact, for papers by Michael D. Greenspan Breakdown of academic impact, for papers by Masakazu Ogata Breakdown of academic impact, for papers by A J Clifford Breakdown of academic impact, for papers by Kévin Ragot Breakdown of academic impact, for papers by Anne J. Smith Breakdown of academic impact, for papers by Lawrence M. Zaccaro Breakdown of academic impact, for papers by Hee Yeon Kim Breakdown of academic impact, for papers by Kenneth H. Shull Breakdown of academic impact, for papers by Theodore W. C. Lo
Rankless by CCL
2026